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Recurrent Streptococcus equi subsp. zooepidemicus Bacteremia in an
Infant
Joshua R. Watson,a Amy Leber,a,b Sridhar Velineni,c John F. Timoney,c Monica I. Arduraa
Department of Pediatrics, Infectious Diseases and Immunology, Nationwide Children’s Hospital, and The Ohio State University, Columbus, Ohio, USAa; Departments of
Pathology and Laboratory Medicine, Nationwide Children’s Hospital, Columbus, Ohio, USAb; Gluck Equine Research Center, University of Kentucky, Lexington, Kentucky,
USAc
We describe a case of an infant with recurrent bacteremia caused by Streptococcus equi subsp. zooepidemicus, likely transmitted
frommother to infant. Our case highlights the importance of an epidemiological history andmolecular diagnostics in ascertain-
ing insights into transmission, pathogenesis, and optimal management.
CASE REPORT
Amale infant was born via spontaneous vaginal delivery to agravida 1, para 1 female at 32 weeks and 6 days of gestation
because of preterm labor with Apgar scores of 7 at 1 min and 8 at
5 min. The mother’s group B streptococcal colonization status was
unknown, and she received 2 doses of ampicillin prior to delivery.
Artificial rupture of membranes occurred approximately 1 h prior
to delivery. Placental pathology was normal. The infant required
continuous positive airway pressure for respiratory distress and
received 1 dose of surfactant. He was admitted to the neonatal
intensive care unit at the delivery hospital and received ampicillin
and gentamicin until a blood culture was negative at 48 h. On day
of life (DOL) 12, the infant developed apnea, bradycardia, and
hypoxemia. Physical examination revealed poor perfusion, poor
tone, and skin erythema on the right side of his neck, chest, and
abdomen. Neck ultrasound demonstrated parotitis and cellulitis,
and blood culture yielded Gram-positive cocci identified by the
outside hospital as group C streptococcus (GCS). He received in-
travenous ampicillin for 10 days with clinical improvement and
clearance of bacteremia. He was discharged home on DOL 23.
The infant did well until DOL 28, when his parents noted nasal
congestion, poor feeding of expressed human milk and infant for-
mula, and decreased activity. On DOL 29, he developed altered
breathing and central cyanosis after a feeding. Transient skin ery-
thema on the right side of the neck was also noted. Review of
systems was negative for fever, cough, emesis, and seizures. At the
Nationwide Children’s Hospital emergency department, he devel-
oped apnea, bradycardia, and hypoxemia requiring intubation
and mechanical ventilation. Laboratory studies and cultures were
obtained, and empirical ampicillin and cefotaxime administration
was initiated. In the pediatric intensive care unit, he required in-
travenous fluid resuscitation, vasopressors, and stress dose corti-
costeroids for hypotension and poor perfusion. A complete blood
count, hepatic panel, and cerebrospinal fluid analysis were unre-
markable. Chest X-ray, echocardiogram, and computed tomogra-
phy of the head and neck were normal. Rhinovirus was detected in
a nasopharyngeal sample by PCR (1). Peripheral blood cultures
were obtained, and the aerobic blood culture was positive for
Gram-positive cocci in pairs and chains at 14 h of incubation
(BacT/Alert FN; bioMérieux, Durham, NC). Initial subculture re-
vealed colonies that were 1 to 2 mm in diameter with a large zone
of beta-hemolysis on sheep blood agar (Fig. 1) and were identified
as GCS based on a negative catalase test and a latex agglutination
result positive for group C antigen (Streptex; Remel, Lenexa, KS).
The initial blood isolate from the outside hospital was also ob-
tained, and the identification of GCS was confirmed by the afore-
mentioned methods. Results of antimicrobial susceptibility test-
ing (2) of both isolates were as follows: susceptible to penicillin
(MIC, 0.03 g/ml, Etest; bioMérieux, Durham, NC), resistant to
clindamycin (disk diffusion), and a rifampin MIC of 0.023 g/ml
(Etest). Culture from the endotracheal tube aspirate also yielded
rare GCS; urine and cerebrospinal fluid cultures were negative.
The infant was extubated on hospital day 6 and demonstrated
continued clinical improvement. He had documented clearance
of bacteremia within 24 h and received 18 days of intravenous
ampicillin. Evaluation for primary immunodeficiency was nega-
tive.
Additional history revealed that 48 h prior to the patient’s first
episode of GCS sepsis, his mother had developed fever and malaise
requiring hospitalization. Her blood and urine cultures were neg-
ative, and her symptoms resolved. Days before the patient’s sec-
ond episode of GCS sepsis, the mother developed pharyngitis. A
throat culture yielded GCS, for which she was prescribed azithro-
mycin. Epidemiological history revealed that the family lived on a
farm in Ohio where the father cared for approximately 100 horses,
none of which were ill.
Throat cultures obtained from both parents during the second
hospitalization were negative for GCS carriage. The infant and his
parents were treated with a 2-day course of rifampin prior to hos-
pital discharge. At a 6-week follow-up appointment, the infant
was clinically well. Throat cultures from the infant and father at
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that time were negative. The mother’s throat culture yielded an
isolate that was identified as described above as GCS susceptible to
penicillin (MIC, 0.03 g/ml), resistant to clindamycin (disk dif-
fusion), and with a rifampin MIC of 0.023 g/ml. Concern that
maternal GCS pharyngeal colonization could serve as a source of
re-exposure of the infant to GCS prompted treatment of the
mother with oral penicillin for 10 days combined with rifampin
during the final 4 days. At an appointment 3 months following the
second hospitalization, the infant continued to do well and had
negative throat and rectal cultures. Maternal throat culture was
also negative at that time. At 16 months of age, the infant has had
no further recurrences of GCS bacteremia or sepsis.
Further phenotypic characterization was performed with the
two blood isolates from the infant and the throat isolate from the
mother (from the 6-week follow-up appointment). The isolates
were identified as Streptococcus equi subsp. zooepidemicus by Vitek
2 (bioMérieux, Durham, NC) by using the Gram-positive identi-
fication card with 99% probability and excellent identification
confidence. The isolates fermented lactose and sorbitol but not
trehalose, consistent with S. equi subsp. zooepidemicus (3). Ma-
trix-assisted laser desorption ionization–time of flight mass spec-
trometry (Vitek MS; bioMérieux, Durham, NC) was performed
and identified all of the isolates as S. equi subsp. zooepidemicus
with a confidence value of 99.9 (Vitek MS IVD version 2.0, un-
claimed identification).
Sequencing of the 16S rRNA genes (MicroSEQ 500 16S rDNA
Bacterial Identification System; Life Technologies, Grand Island,
NY) of the three isolates revealed identical 499-bp consensus se-
quences. Comparison to sequences available in databases at the
National Center for Biotechnology Information, MicroSEQ v2.1,
and SmartGene (Lausanne, Switzerland) showed that our isolates
clustered closely with S. equi subsp. equi and zooepidemicus, but
the sequence length was not sufficient to reliably distinguish be-
tween the two subspecies.
Analysis of the isolates by pulse-field gel electrophoresis
(PFGE) with SmaI revealed that the two blood isolates from the
infant were indistinguishable from one another. The PFGE pat-
tern of the isolate from the mother’s throat culture had two bands
different from the infant’s blood isolates, a difference that may be
explained by a single genetic event (4). The PFGE results indicate
that the mother’s isolate was closely related to the infant’s isolates
and was probably the same strain.
Additional molecular characterization of the isolates is shown
in Table 1. The S. equi subsp. zooepidemicus szm and szp genes were
detected and sequenced (5) and were identical in the three isolates.
Molecular detection of S. equi subsp. equi genes eqbN and se18.9
was also attempted (6, 7). Absence of eqbN and se18.9 (as found in
S. equi subsp. equi), together with the presence of identical szm
and szp sequences typical of S. equi subsp. zooepidemicus, in all
three isolates confirmed the identification and supported the
conclusion that the isolates from the infant and the mother were
the same strain of S. equi subsp. zooepidemicus. Multilocus se-
quence typing (MLST) (5) revealed that all three isolates had the
same novel sequence type, 190 (ST190) (http://pubmlst.org
/szooepidemicus/). As may be seen in S. equi subsp. zooepidemicus,
superantigen genes szeN and szeP, but not szeF, were detected by
PCR (8).
This report describes, to our knowledge, the first case of recur-
rent S. equi subsp. zooepidemicus infection in a young infant. Ep-
idemiological history prompted a detailed molecular character-
ization that identified the bacterial isolates as S. equi subsp.
FIG 1 Subculture of the infant’s blood isolate on sheep blood agar after 24 h of
incubation at 35°C in 5% CO2. Colonies were 1 to 2 mm in diameter, slightly
umbonate, shiny, and gray to clear with entire edges and a large zone of beta-
hemolysis. The final identification was S. equi subsp. zooepidemicus.
TABLE 1 Molecular characterization of S. equi subsp. zooepidemicus clinical isolates from infant and mothera
Source of bacterial isolate MLST result
S. equi subsp. zooepidemicus S. equi subsp. equi
SzP proteinb SzM proteinc szeF szeN szeP eqbN se18.9
Infant’s blood
Initial episode ST190 N2HV5, 5PEPK A3(b), B2 tandem repeats Absent Present Present Absent Absent
Recurrent episode ST190 N2HV5, 5PEPK A3(b), B2 tandem repeats Absent Present Present Absent Absent
Mother’s throat at 6-wk follow-up ST190 N2HV5, 5PEPK A3(b), B2 tandem repeats Absent Present Present Absent Absent
a SzP, protective protein; SzM, M-like protein; szeF, szeN, and szeP, superantigen genes; eqbN, equibactin gene of S. equi subsp. equi; se18.9, gene for factor H binding protein of S.
equi subsp. equi; N2HV5, N-terminal N2 and hypervariable 5 sequence motifs; 5PEPK, five carboxy-terminal PEPK repeats.
b The N, HV, and PEPK regions of SzP are variable among isolates of S. equi subsp. zooepidemicus. The genes were completely sequenced and were identical in all three isolates (18).
c The A and B regions of SzM are variable among isolates of S. equi subsp. zooepidemicus. The genes were completely sequenced and were identical in all three isolates (19).
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zooepidemicus (ST190) and elucidated the mother as the potential
source. This result provided a risk factor that could be modified to
prevent future disease.
S. equi subsp. zooepidemicus and its clonal derivative S. equi
subsp. equi share high DNA homology but differ in their patho-
genicity (9). S. equi subsp. equi is the causative agent of a highly
contagious respiratory tract infection of horses called strangles. S.
equi subsp. zooepidemicus, in contrast, is a commensal organism of
equine mucosal surfaces that may cause invasive infections in
horses during times of viral infection, heat stress, or tissue injury
(8, 9).
The production of superantigens may be important in the
pathogenesis of S. equi subsp. zooepidemicus infections. Similar to
Streptococcus pyogenes, three genes encoding superantigens (szeF,
szeN, and szeP) have been described in the S. equi subsp. zooepi-
demicus genome (8). Of 165 S. equi subsp. zooepidemicus isolates
examined by Paillot et al. (8), one or more superantigens were
detected in 49%. The three superantigens possess a characteristic
amino acid sequence signature, and their amino acid sequences
are 34 to 59% identical to those of superantigens produced by S.
pyogenes. The presence of szeN and szeP was associated with mi-
togenic activity, but the presence of szeF was not. In our case, both
szeN and szeP, but not szeF, were detected.
Cases of S. equi subsp. zooepidemicus infections in adults with
close and continuous contact with horses and dogs have been
described previously (10, 11). A search of the MEDLINE database
for English-language publications of infections in infants 3
months of age with the key words “Group C Strep*,” “Streptococ-
cus equi,” and “Streptococcus zooepidemicus” yielded three prior
reports that identified S. equi subsp. zooepidemicus causing men-
ingitis and sepsis (12–14). Two of the cases occurred during out-
breaks related to the consumption of unpasteurized cow’s milk
but without confirmation of infection in family members of the
infants (12, 13). Another report of S. equi subsp. zooepidemicus
infection described a 14-week-old infant whose family owned a
horse (15). In that case, the mother had a lower respiratory tract
infection 3 weeks before the infant’s illness, but she was not tested
for S. equi subsp. zooepidemicus colonization. In the case of our
infant, results of molecular analysis supported mother-to-infant
transmission. Although we questioned the possibility of an equine
reservoir, we were unable to test the horses to confirm a zoonosis.
No cases of recurrent S. equi subsp. zooepidemicus infection dur-
ing the first 3 months of life were found in the published literature.
Because of concern that the patient’s mother was a chronic
pharyngeal carrier of S. equi subsp. zooepidemicus, she was treated
with penicillin and rifampin according to guidelines for chronic S.
pyogenes carriage (16, 17). We believed this was a necessary inter-
vention given the infant’s recurrent episodes of sepsis, prematu-
rity, and immature immune system. This strategy appeared to be
successful at least temporarily, as evidenced by a negative maternal
throat culture at the 3-month follow-up visit and lack of disease
recurrence in the infant.
In conclusion, this report describes the first case of recurrent
bacteremia in a young infant caused by S. equi subsp. zooepi-
demicus, likely transmitted from mother to infant. Molecular
characterization of bacterial isolates was essential to determine the
precise identity of the pathogen and to identify modifiable risk
factors for recurrent infection. Additionally, molecular tech-
niques detected superantigen genes that may explain the orga-
nism’s pathogenicity. Clinicians should be aware that S. equi
subsp. zooepidemicus may cause invasive infections in young in-
fants and that recurrence is possible.
Nucleotide sequence accession numbers. The nucleotide se-
quences of the S. equi subsp. zooepidemicus szm and szp genes have
been deposited in the GenBank database and assigned accession
numbers KP735516 (szm) and KP735515 (szp).
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